Format

Send to

Choose Destination
Nat Rev Cancer. 2003 Jun;3(6):459-65. doi: 10.1038/nrc1097.

RAS oncogenes: the first 30 years.

Author information

1
Molecular Oncology Programme, Centro Nacional de Investigaciones Oncológicas, Melchor Fernández Almagro 3, 28029 Madrid, Spain. marcos.malumbres@cnio.es

Erratum in

  • Nat Rev Cancer. 2003 Sep;3(9):708.

Abstract

From the pioneering work with acute transforming retroviruses to the current post-genomic era, RAS genes have always been at the leading edge of signal transduction and molecular oncology. Yet, a complete understanding of RAS function and dysfunction - mainly in human cancer - is still to come. The knowledge that has accumulated since their discovery 30 years ago has, however, been remarkable, and should pave the way for not only solving the outstanding issues regarding RAS biology, but also for developing efficacious drugs that could have a significant impact on cancer treatment.

PMID:
12778136
DOI:
10.1038/nrc1097
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center